European Medical Solutions
ALEMS.BR · BRU
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.27 | 0.56 | 0.24 | 0.27 |
| FCF Yield | -4.00% | -14.23% | -0.14% | -29.14% |
| EV / EBITDA | 11.06 | 23.18 | -74.07 | 8.03 |
| Quality | ||||
| ROIC | 2.57% | -0.44% | -20.24% | 0.12% |
| Gross Margin | 33.14% | 33.31% | 37.18% | 36.31% |
| Cash Conversion Ratio | 4.67 | 3.21 | -0.38 | -1.44 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.79% | 2.18% | 369.11% | 229.29% |
| Free Cash Flow Growth | 79.02% | -4,039.32% | 92.56% | -14.23% |
| Safety | ||||
| Net Debt / EBITDA | 4.33 | 6.66 | -7.97 | 5.40 |
| Interest Coverage | 1.83 | -0.31 | -22.33 | 0.15 |
| Efficiency | ||||
| Inventory Turnover | 2.32 | 1.88 | 1.78 | 2.09 |
| Cash Conversion Cycle | 103.56 | 146.77 | 162.02 | 151.13 |